Company intelligence / Profile preview
Vivani Medical
Alameda, California, United States
- Ownership
- Public · VANI
- Employees
- ~37
- Development stage
- Other
01
Overview
Vivani is developing subdermal drug implants targeting chronic weight management (NPM-115, high-dose exenatide, in clinical stage), type 2 diabetes (NPM-119, preclinical), and visual prosthetic implants (via subsidiary Cortigent); NPM-115 is in clinical development for obesity, NPM-119 for diabetes is in preclinical stage[1][3].
- Therapeutic areas
- NeurologyEndocrinologyMetabolic DisordersOphthalmology
- Modalities
- DeviceSmall moleculePeptidesBiologic
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Vivani Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vivani Medical.